Azienda Ospedaliero-Universitaria di Ferrara-Arcispedale Sant'Anna

Cona 44124

2 studies enrolling now · 5 studies all time

What they study most

Atherosclerosis, Cardiovascular Diseases, Duchenne Muscular Dystrophy, Heart Failure, Heart Failure With Reduced Ejection Fraction, Hypertriglyceridemia, Severe Hypertriglyceridemia, Transthyretin Amyloidosis (ATTR) With Cardiomyopathy

Studies at this site

• Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction — Recruiting now
• MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM) — Recruiting now
• A Study of Olezarsen (ISIS 678354) in Participants With Hypertriglyceridemia and Atherosclerotic Cardiovascular Disease, or With Severe Hypertriglyceridemia — Completed
• A Study of Olezarsen Administered Subcutaneously to Participants With Severe Hypertriglyceridemia — Completed
• An Extension Study to Evaluate Casimersen or Golodirsen in Patients With Duchenne Muscular Dystrophy — Stopped early